Comparison of Captisol-Enabled ™ Iohexol and Omnipaque™ in Patients With Impaired Renal Function Undergoing Coronary Angiography
Condition: Contrast-induced Nephropathy Interventions: Drug: CE-Iohexol; Drug: Iohexol Sponsor: Ligand Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials